Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage

BACKGROUND: Patients with hematological malignancies often develop febrile neutropenia (FN) as a complication of cancer chemotherapy. Primary or secondary antifungal prophylaxis is recommended for patients with hematological malignancies to reduce the risk of invasive fungal infection (IFI). This st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gedik, Habip, Şimşek, Funda, Yıldırmak, Taner, Kantürk, Arzu, Arıca, Deniz, Aydın, Demet, Demirel, Naciye, Yokuş, Osman
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4011927/
https://ncbi.nlm.nih.gov/pubmed/24855365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S59683
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados